$ABOS
Acumen Pharmaceuticals, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is ABOS up today? It is at $3.22 (+1.04%), and our scanner flagged it 11 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ABOS spikes, and full due diligence on ABOS — key stats, earnings, dilution and insider activity. Free.
Get free $ABOS alerts the moment volume spikes
Our scanner flagged $ABOS 11 times in the last 30 days. Create a free account to track $ABOS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $3.22
- Change today
- +1.04%
- Previous close
- $3.19
- 52-week range
- $1.21 – $3.60
- Market cap
- $229M
- Shares outstanding
- 72.3M SEC · as of 2026-08-07 · 16d
- Institutional own.
- 69.10%
- Total held
- 80.3%
- Tradeable float
- 14.2M 20% of shares · after 11% insiders + 69% institutions
- Short interest
- 3.4M ▲ +20% vs prior · as of 2026-07-31
- Short % of float
- 23.7%
- Days to cover
- 9.5d
- Avg daily volume
- 477K
- Sector
- Health Care
- Industry
- Biological Products, (No Diagnostic Substances)
- Exchange
- XNAS
- 5mthin
- 155x
- 15mthin
- 155x
- 1hthin
- 155x
- 1D
- --
Get free ABOS + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $ABOS up today?
Here is the latest on ABOS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ABOS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystAcumen Pharmaceuticals, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Insiders
Insiders buying8 buys, 4 sells last 3 months (16/44 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Porter Derrell Director | Sold (automatic/other) | -13K 0.02% of company | sold 27% | 36K | $30K at $2.33 | Jun 17, 26 |
Porter Derrell Director | Other | 13K 0.02% of company | added 37% | 49K | $14K at $1.07 | Jun 17, 26 |
Porter Derrell Director | Sold (automatic/other) | -13K 0.02% of company | sold 27% | 36K | $30K at $2.33 | Jun 16, 26 |
Porter Derrell Director | Sold (automatic/other) | -6K | sold 12% | 48K | $15K at $2.35 | Jun 15, 26 |
Porter Derrell Director | Other | 6K | added 13% | 55K | $7K at $1.07 | Jun 15, 26 |
Fountain Nathan B Director | Sold (automatic/other) | -6K | sold 12% | 48K | $14K at $2.23 | Jun 9, 26 |
Stoppel Laura Director | Acquired (grant/award) | +36K 0.05% of company | added 100% | 48K | n/a | Jun 3, 26 |
Golumbeski George Director | Acquired (grant/award) | +36K 0.05% of company | n/a | 36K | n/a | Jun 3, 26 |
Ives Jeffrey L. Director | Acquired (grant/award) | +36K 0.05% of company | added 100% | 48K | n/a | Jun 3, 26 |
Porter Derrell Director | Acquired (grant/award) | +36K 0.05% of company | added 100% | 48K | n/a | Jun 3, 26 |
Stalfort John A Iii Director | Acquired (grant/award) | +36K 0.05% of company | added 19% | 221K | n/a | Jun 3, 26 |
Drapkin Kimberlee C Director | Acquired (grant/award) | +36K 0.05% of company | added 100% | 48K | n/a | Jun 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
UnavailableWe could not reach SEC EDGAR, so the dilution check did not run for $ABOS. This is not a clean result: there may be an offering, a registration or a shelf on file that we were unable to read. Check it yourself on SEC EDGAR before trading it.
$ABOS Sentiment
NeutralBlend of news sentiment, today’s move, and community votes. Not investment advice.
$ABOS Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to ABOS
Comparable names in biological products, (no diagnostic substances), closest in size first.
ABOS stock FAQ
Why is $ABOS up today?
Here is the latest on ABOS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for ABOS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the ABOS stock price today?
ABOS last traded at $3.22, up 1.04% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live ABOS alerts?
The ABOS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ABOS 11 times in the last 30 days.
What exchange is ABOS on?
ABOS (Acumen Pharmaceuticals, Inc. Common Stock) trades on XNAS, with a market cap of about $229M in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Is ABOS good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ABOS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.